Value-Based Quality Care for Breast Cancer: More Than Guidelines
Yıl: 2021 Cilt: 17 Sayı: 4 Sayfa Aralığı: 11 - 14 Metin Dili: İngilizce DOI: 10.4274/ejbh.galenos.2021.6333 İndeks Tarihi: 25-01-2022
Value-Based Quality Care for Breast Cancer: More Than Guidelines
Öz: Although guidelines recommend some of the most expensive diagnostic methods and therapies, some patients do have the opportunity to use them, but some others have overused or misused such methods. The cost of cancer care is increasing, but the satisfaction levels of patients and healthcare workers have not increased in line with this rise. Value-based care for cancer, especially breast cancer, should be implemented. For this reason, all unnecessary screening, tests, treatments, and follow-up parameters should be avoided.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- Kuznar W. NCCN Panel addresses value-based care in oncology. Value-Based Cancer Care 2015; 6(3). Available at: https://www. valuebasedcancer.com/issues/2015/april-2015-vol-6-no-3/764-nccnpanel-addresses-value-based-care-in-oncology [Crossref]
- Güler SA, Cantürk NZ. Multidisciplinary breast cancer teams and proposed standards. Ulus Cerrahi Derg 2014; 31: 39-41. (PMID: 25931943) [Crossref]
- Pittal Hankal A, Davidson T. Care pathways for patients with breast cancer. Trends Urol Gynaecol Sex Health 2010; 15: 10-13. [Crossref]
- Lee PV, Berenson RA, Tooker J Payment reform—the need to harmonize approaches in Medicare and the private sector. N Engl J Med 2010; 362: 3-5. (PMID: 20007550) [Crossref]
- Levin-Scherz J. what drives high health care costs--and how to fight back. Harv Bus Rev 2010; 88: 72-73. (PMID: 20402058) [Crossref]
- Mariotto AB Yabroff KB, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103: 117-128. (PMID: 21228314) [Crossref]
- Feeley TW, Fly HS, Albright H, Walters R, Burke TW. A method for defining value in healthcare using cancer cares a model. J Healthc Manag 2010; 55: 399-411; discussion 411-2. (PMID: 21166323) [Crossref]
- Rosen R, Curry N, Florin D. Public Views on Choices in Health and Health Care. Available at: https://www.kingsfund.org.uk/sites/default/ files/PublicViewsOnChoices.pdf [Crossref]
- Wennberg J, McPherson K, Goodman D. Small area analysis and the challenge of practice variation. In: Johnson A, Stukel T, editors. Medical practice variations. health services research. Boston, MA: Springer:2015. [Crossref]
- Merriam-Webster Dictionary 2011. Available at: https://www. merriamwebster.com/dictionary [Crossref]
- Kohn LT, Corrigan JM, Donaldson MS, editors. Institute of Medicine (US) committee on quality of health care in america to err is human: building a safer health system. Washington (DC): National Academies Press (US); 2000. [Crossref]
- Institute of Medicine (US) Committee on Quality of Health Care in America Crossing the Quality Chasm: A New Health System for the 21st CenturyWashington (DC): National Academies Press (US); 2001 (PMID: 25057539) [Crossref]
- Agency for healthcare research and quality, 2010. Available at: https:// www.ahrq.gov/ [Crossref]
- Putera I. Redefining health: implication for value based healthcare. Cureus 2017; 9: e1067. (PMID: 28409068) [Crossref]
- Ozmen V, Boylu S, Ok E, Canturk NZ, Celik V, Kapkac M, et al. Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies. Eur J Public Health 2015; 25: 9-14. (PMID: 25096257) [Crossref]
- Shih YC, Ganz PA, Aberle D, Abernethy A, Bekelman J, Brawley O, et al. Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol 2013; 31: 4151-4157. (PMID: 24127450) [Crossref]
- Wright JD, Neugut AI, Ananth CV, Lewin SN, Wilde ET, Lu Y-S, et al. Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes. JAMA Intern Med 2013; 173: 559- 568. (PMID: 23460379) [Crossref]
- Faden RR, Chalkidou K, Appleby J, Waters HR, Leider JP. Expensive cancer drugs: a comparison between the United States and the United Kingdom. Milbank Q 2009; 87: 789-819. (PMID: 20021586) [Crossref]
- OECD Reviews of Health Care Quality TURKEY, 2014. Available at: https://www.oecd.org/turkey/oecd-reviews-of-health-care-quality-turkey2013-9789264202054-en.htm [Crossref]
- Dugdale DC, Epstein R, Pantilat SZ. Time and the patient–physician relationship. J Gen Intern Med 1999; 14(Suppl 1): S34-S40. (PMID: 9933493) [Crossref]
- ASCO News & analysis. https://www.asco.org/practice-policy/ policy-issues-statements/asco-in-action/asco-action-brief-valuecancer care#:~:text=In%202007%2C%20ASCO%20established%20 the,quality%2C%20and%20value%20in%20concert. [Crossref]
- Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, et al. American Society of Clinical Oncology Guidance Statement: the cost of cancer care. J Clin Oncol 2009; 27: 3868-3874. (PMID: 19581533) [Crossref]
- Yilmaz OC, Cantürk NZ, Kebudi A, Güler SA, Erkek A, Rezai M, et al. The emerging role of national academies in surgical training: an inspiring environment for increasing the quality of health care in breast cancer management. J Cancer Educ 2014; 29: 395-400. (PMID: 24515563) [Crossref]
- Schickedanz AD, Schillinger D, Landefeld CS, Knight SJ, Williams BA, Sudore RL. A clinical framework for improving the advance care planning process: start with patients' self-identified barriers J Am Geriatr Soc 2009; 57: 31-39. (PMID: 19170789) [Crossref]
- Schnipper LE, Davidson NE, Wollins Ds, Tyne C, Blayney DW, Blum D, et al. American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol 2015; 33: 2563-2577. (PMID: 26101248) [Crossref]
- Lemieux J, Audet S. Value assessment in oncology drugs: funding of drugs for metastatic breast cancer in Canada. Curr Oncol 2018; 25: S161-S170. (PMID: 29910659) [Crossref]
- Biganzoli L, Marotti L, Hart CD, Cataliotti L, Cutuli B, Kuhn T, et al. Quality indicators in breast cancer care: an update from the EUSOMA working group. Eur J Cancer 2017; 86: 59-81. (PMID: 28963914) [Crossref]
- Fayanju OM, MayoTl, Spinks TE, Lee, S, Bercenas CH, Smith BD, et al. Value-based breast cancer care: a multidisciplinary approach for defining patient centered outcomes. Ann Surg Oncol 2016; 23: 2385-2390. (PMID: 26979306) [Crossref]
- Mosadeghrad AM. Factors affecting medical service quality. Iran J Public Health 2014; 43: 210-220. (PMID: 26060745) [Crossref]
- Costa RLB, Gradishar WJ. Do genomic assays provide the necessary confidence to de-escalate adjuvant therapy? J Clin Oncol 2018; 36: 725- 727. (PMID: 29373092)
- Sepucha KR, Belkora J. Importance of decision quality in breast cancer care. Psicooncologia 2010; 7:313-328. [Crossref]
- Gathirua-Mwangi WG, Monahan PO, Stump T, Rawl SM, Skinner C, Champion VL. Mammography adherence in African American Women: results of a randomized controlled. J Ann Behav Med 2016; 50: 70-78. (PMID: 26416127) [Crossref]
- Nixon N, Verma S. A value based approach to treatment of HER-2 positive breast cancer. ASCO Educational Book 2016: e56-63. [Crossref]
- Yang SK, Cho N, Moon WK. The role of PET/CT for evaluating breast cancer. Korean J Radiol 2007; 8: 429-437. (PMID: 17923786) [Crossref]
- Smith TJ. Breast cancer surveillance guidelines. J Oncol Pract 2013; 9: 65-67.
- Rojas MP, Telaro E, Russo A, et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 2005;CD001768. (PMID: 15674884) [Crossref
| APA | Canturk N, Gulluoglu M (2021). Value-Based Quality Care for Breast Cancer: More Than Guidelines. , 11 - 14. 10.4274/ejbh.galenos.2021.6333 |
| Chicago | Canturk Nuh Zafer,Gulluoglu Mahmut Bahadir Value-Based Quality Care for Breast Cancer: More Than Guidelines. (2021): 11 - 14. 10.4274/ejbh.galenos.2021.6333 |
| MLA | Canturk Nuh Zafer,Gulluoglu Mahmut Bahadir Value-Based Quality Care for Breast Cancer: More Than Guidelines. , 2021, ss.11 - 14. 10.4274/ejbh.galenos.2021.6333 |
| AMA | Canturk N,Gulluoglu M Value-Based Quality Care for Breast Cancer: More Than Guidelines. . 2021; 11 - 14. 10.4274/ejbh.galenos.2021.6333 |
| Vancouver | Canturk N,Gulluoglu M Value-Based Quality Care for Breast Cancer: More Than Guidelines. . 2021; 11 - 14. 10.4274/ejbh.galenos.2021.6333 |
| IEEE | Canturk N,Gulluoglu M "Value-Based Quality Care for Breast Cancer: More Than Guidelines." , ss.11 - 14, 2021. 10.4274/ejbh.galenos.2021.6333 |
| ISNAD | Canturk, Nuh Zafer - Gulluoglu, Mahmut Bahadir. "Value-Based Quality Care for Breast Cancer: More Than Guidelines". (2021), 11-14. https://doi.org/10.4274/ejbh.galenos.2021.6333 |
| APA | Canturk N, Gulluoglu M (2021). Value-Based Quality Care for Breast Cancer: More Than Guidelines. European Journal of Breast Health, 17(4), 11 - 14. 10.4274/ejbh.galenos.2021.6333 |
| Chicago | Canturk Nuh Zafer,Gulluoglu Mahmut Bahadir Value-Based Quality Care for Breast Cancer: More Than Guidelines. European Journal of Breast Health 17, no.4 (2021): 11 - 14. 10.4274/ejbh.galenos.2021.6333 |
| MLA | Canturk Nuh Zafer,Gulluoglu Mahmut Bahadir Value-Based Quality Care for Breast Cancer: More Than Guidelines. European Journal of Breast Health, vol.17, no.4, 2021, ss.11 - 14. 10.4274/ejbh.galenos.2021.6333 |
| AMA | Canturk N,Gulluoglu M Value-Based Quality Care for Breast Cancer: More Than Guidelines. European Journal of Breast Health. 2021; 17(4): 11 - 14. 10.4274/ejbh.galenos.2021.6333 |
| Vancouver | Canturk N,Gulluoglu M Value-Based Quality Care for Breast Cancer: More Than Guidelines. European Journal of Breast Health. 2021; 17(4): 11 - 14. 10.4274/ejbh.galenos.2021.6333 |
| IEEE | Canturk N,Gulluoglu M "Value-Based Quality Care for Breast Cancer: More Than Guidelines." European Journal of Breast Health, 17, ss.11 - 14, 2021. 10.4274/ejbh.galenos.2021.6333 |
| ISNAD | Canturk, Nuh Zafer - Gulluoglu, Mahmut Bahadir. "Value-Based Quality Care for Breast Cancer: More Than Guidelines". European Journal of Breast Health 17/4 (2021), 11-14. https://doi.org/10.4274/ejbh.galenos.2021.6333 |
